A world leader in allogeneic adult stem cell manufacturing and research, Stemedica Cell Technologies, Inc. announced the completion of its proprietary master bank of mesenchymal bone marrow-derived stem cells.

Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica's allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the Uni